Brief, factual summary of the article in Slovak: The article addresses the question of whether funding cuts to naloxone, an opioid overdose drug, will lead to more deaths. Naloxone is important in the treatment of opioid overdoses, and its availability is critical to saving lives. However, the article does not provide specific data or statistics that would confirm or refute the possible consequences of reducing naloxone funding. Instead, it offers only a general discussion of the issue without presenting any verified facts.